NuCana (NCNA) Receivables - Affiliates (2021 - 2024)
NuCana's (NCNA) quarterly Receivables - Affiliates came in at $560890.3 in Q4 2024, up 8.63% year-on-year from $516319.2 in Q1 2024, and up 8.63% quarter-over-quarter from $516319.2 in Q4 2023.
NuCana (NCNA) Receivables - Affiliates (2021 - 2024) Analysis & Trends
NuCana has disclosed Receivables - Affiliates across 4 years of filings, most recently posting $560890.3 for Q4 2024.
- Receivables - Affiliates for Q4 2024 came in at $560890.3, up 8.63% year-over-year; the trailing twelve-month figure through Dec 2024 was $560890.3 (up 8.63% YoY), and the FY2024 annual result was $558606.3, up 7.96% from the prior year.
- Receivables - Affiliates came in at $560890.3 for Q4 2024 at NuCana, up from $516319.2 in the prior quarter.
- In the past five years, Receivables - Affiliates ranged from a high of $560890.3 in Q4 2024 to a low of $465652.5 in Q4 2022.
- The 4-year median for Receivables - Affiliates is $520347.7 (2021), against an average of $516809.5.
- Across the five-year window, Receivables - Affiliates decreased 11.2% in 2022 and gained 10.88% in 2023, its largest moves.
- NuCana's Receivables - Affiliates stood at $524376.1 in 2021, then decreased by 11.2% to $465652.5 in 2022, then advanced by 10.88% to $516319.2 in 2023, then grew by 8.63% to $560890.3 in 2024.
- The last three Receivables - Affiliates figures came in at $560890.3 (Q4 2024), $516319.2 (Q4 2023), and $465652.5 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Affiliates (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 560,890.30 |
| Dec 31, 2024 | 560,890.30 |
| Dec 31, 2023 | 516,319.18 |
| Dec 31, 2023 | 516,319.18 |
| Dec 31, 2022 | 465,652.54 |
| Dec 31, 2022 | 465,652.54 |
| Dec 31, 2021 | 524,376.13 |
| Dec 31, 2021 | 524,376.13 |